BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

171 related articles for article (PubMed ID: 19703300)

  • 21. Measuring patients' expectations regarding health-related quality-of-life outcomes associated with prostate cancer surgery or radiotherapy.
    Symon Z; Daignault S; Symon R; Dunn RL; Sanda MG; Sandler HM
    Urology; 2006 Dec; 68(6):1224-9. PubMed ID: 17141840
    [TBL] [Abstract][Full Text] [Related]  

  • 22. How potent is potent? Evaluation of sexual function and bother in men who report potency after treatment for prostate cancer: data from CaPSURE.
    Cooperberg MR; Koppie TM; Lubeck DP; Ye J; Grossfeld GD; Mehta SS; Carroll PR;
    Urology; 2003 Jan; 61(1):190-6. PubMed ID: 12559294
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Cross validation of the prostate cancer radiotherapy late toxicity (PCRT) questionnaire with the expanded prostate cancer index composite (EPIC) instrument.
    Rodrigues G; Bauman G; Venkatesan V; Ahmad B; Lock M; Sexton T; D'Souza D; Stitt L; Eid S
    Can J Urol; 2011 Aug; 18(4):5802-10. PubMed ID: 21854712
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Quality of life in men living with advanced and localised prostate cancer in the UK: a population-based study.
    Downing A; Wright P; Hounsome L; Selby P; Wilding S; Watson E; Wagland R; Kind P; Donnelly DW; Butcher H; Catto JWF; Cross W; Mason M; Sharp L; Weller D; Velikova G; McCaughan E; Mottram R; Allen M; Kearney T; McSorley O; Huws DW; Brewster DH; McNair E; Gavin A; Glaser AW
    Lancet Oncol; 2019 Mar; 20(3):436-447. PubMed ID: 30713036
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Contemporary prevalence of pretreatment urinary, sexual, hormonal, and bowel dysfunction: Defining the population at risk for harms of prostate cancer treatment.
    Resnick MJ; Barocas DA; Morgans AK; Phillips SE; Chen VW; Cooperberg MR; Goodman M; Greenfield S; Hamilton AS; Hoffman KE; Kaplan SH; Paddock LE; Stroup AM; Wu XC; Koyama T; Penson DF
    Cancer; 2014 Apr; 120(8):1263-71. PubMed ID: 24510400
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Bother problems in prostate cancer patients after curative treatment.
    Stensvold A; Dahl AA; Brennhovd B; Småstuen MC; Fosså SD; Lilleby W; Steinsvik A; Axcrona K; Smeland S
    Urol Oncol; 2013 Oct; 31(7):1067-78. PubMed ID: 22341412
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Health-related quality of life and psychosocial factors in patients with prostate cancer scheduled for radical prostatectomy or external radiation therapy.
    Van Andel G; Visser AP; Hulshof MC; Horenblas S; Kurth KH
    BJU Int; 2003 Aug; 92(3):217-22. PubMed ID: 12887470
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Changes in sexual roles and quality of life for gay men after prostate cancer: challenges for sexual health providers.
    Hart TL; Coon DW; Kowalkowski MA; Zhang K; Hersom JI; Goltz HH; Wittmann DA; Latini DM
    J Sex Med; 2014 Sep; 11(9):2308-17. PubMed ID: 24888965
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Patient-reported outcome measures after treatment for prostate cancer: Results from the Danish Prostate Cancer Registry (DAPROCAdata).
    Nguyen-Nielsen M; Møller H; Tjønneland A; Borre M
    Cancer Epidemiol; 2020 Feb; 64():101623. PubMed ID: 31760356
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Comprehensive comparison of health-related quality of life after contemporary therapies for localized prostate cancer.
    Wei JT; Dunn RL; Sandler HM; McLaughlin PW; Montie JE; Litwin MS; Nyquist L; Sanda MG
    J Clin Oncol; 2002 Jan; 20(2):557-66. PubMed ID: 11786586
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Neoadjuvant hormonal therapy impairs sexual outcome among younger men who undergo external beam radiotherapy for localized prostate cancer.
    Hollenbeck BK; Wei JT; Sanda MG; Dunn RL; Sandler HM
    Urology; 2004 May; 63(5):946-50. PubMed ID: 15134986
    [TBL] [Abstract][Full Text] [Related]  

  • 32. A prospective longitudinal study comparing the impact of external radiation therapy with radical prostatectomy on health related quality of life (HRQOL) in prostate cancer patients.
    van Andel G; Visser AP; Zwinderman AH; Hulshof MC; Horenblas S; Kurth KH
    Prostate; 2004 Mar; 58(4):354-65. PubMed ID: 14968436
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Cross-cultural adaptation and validation of the French version of the Expanded Prostate cancer Index Composite questionnaire for health-related quality of life in prostate cancer patients.
    Anota A; Mariet AS; Maingon P; Joly F; Bosset JF; Guizard AV; Bittard H; Velten M; Mercier M
    Health Qual Life Outcomes; 2016 Dec; 14(1):168. PubMed ID: 27923377
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Health-related quality of life using SF-8 and EPIC questionnaires after treatment with radical retropubic prostatectomy and permanent prostate brachytherapy.
    Hashine K; Kusuhara Y; Miura N; Shirato A; Sumiyoshi Y; Kataoka M
    Jpn J Clin Oncol; 2009 Aug; 39(8):502-8. PubMed ID: 19477898
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Health-related quality of life after radical retropubic prostatectomy and permanent prostate brachytherapy: a 3-year follow-up study.
    Hashine K; Yuasa A; Shinomori K; Ninomiya I; Kataoka M; Yamashita N
    Int J Urol; 2011 Dec; 18(12):813-9. PubMed ID: 21995507
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Association of neoadjuvant hormonal therapy with adverse health-related quality of life after permanent iodine-125 brachytherapy for localized prostate cancer.
    Pinkawa M; Fischedick K; Gagel B; Piroth MD; Borchers H; Jakse G; Eble MJ
    Urology; 2006 Jul; 68(1):104-9. PubMed ID: 16806434
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Mediterranean diet after prostate cancer diagnosis and urinary and sexual functioning: The health professionals follow-up study.
    Bauer SR; Van Blarigan EL; Stampfer MJ; Chan JM; Kenfield SA
    Prostate; 2018 Feb; 78(3):202-212. PubMed ID: 29194691
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Long-term health-related quality of life after primary treatment for localized prostate cancer: results from the CaPSURE registry.
    Punnen S; Cowan JE; Chan JM; Carroll PR; Cooperberg MR
    Eur Urol; 2015 Oct; 68(4):600-8. PubMed ID: 25242555
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Impact of comorbidity on health-related quality of life after prostate cancer treatment: combined analysis of two prospective cohort studies.
    Reeve BB; Chen RC; Moore DT; Deal AM; Usinger DS; Lyons JC; Talcott JA
    BJU Int; 2014 Dec; 114(6b):E74-E81. PubMed ID: 24588845
    [TBL] [Abstract][Full Text] [Related]  

  • 40. A systematic review of expanded prostate cancer index composite (EPIC) quality of life after surgery or radiation treatment.
    Lee TK; Breau RH; Mallick R; Eapen L
    Can J Urol; 2015 Feb; 22(1):7599-606. PubMed ID: 25694006
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.